Initial pharmacotherapy in a population of veterans with Parkinson disease

被引：15

作者：

Swarztrauber, K

Koudelka, C

Brodsky, MA

机构：

[1] Portland VA Med Ctr, Portland, OR USA

[2] Parkinson Dis Res Educ & Clin Ctr, Portland, OR USA

[3] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA

[4] Oregon Hlth Sci Univ, Dept Biostat & Bioinformat Shared Resources, Portland, OR USA

[5] Oregon Hlth Sci Univ, Ctr Biostat Comp & Informat Biol & Med, Portland, OR USA

来源：

NEUROLOGY | 2006年 / 66卷 / 09期

关键词：

D O I：

10.1212/01.wnl.0000210433.49727.40

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The authors analyzed patient and prescribing provider characteristics for 530 veterans identified from VA pharmacy records with Parkinson disease (PD) and initial pharmacotherapy. Neurologists prescribed 29% of initial therapy. While a patient being younger and seeing a movement disorder specialist predicted receiving dopamine agonists, only 20% of patients younger than age 65 years received dopamine agonists. Initial pharmacotherapy is strongly influenced by the provider's specialty but mostly initiated by providers without PD expertise.

引用

页码：1425 / 1426

页数：2

共 9 条

[1] Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
Holloway, R
Shoulson, I
Kieburtz, K
McDermott, M
Tariot, P
Kamp, C
Day, D
Shinaman, A
Fahn, S
Lang, A
Marek, K
Seibyl, J
Weiner, W
Welsh, M
Pahwa, R
Coe, S
Barclay, L
Sutherland, L
Hildebrand, K
Hubble, J
Weeks, C
LeWitt, P
Miyasaki, J
Duff, J
Sime, E
Suchowersky, O
Stacy, M
Kurth, M
Brewer, M
Harrigan, M
Russell, DS
Fussell, B
Ford, B
Dillon, S
Hammerstad, J
Stone, C
Riley, D
Rainey, P
Standaert, D
Tennis, M
Wooten, F
Rost-Ruffner, E
Factor, S
Brown, D
Jankovic, J
Atassi, F
Kurlan, R
Gardiner, I
Panisset, M
Amyot, D
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15): : 1931 - 1938
[2] Montastruc JL, 1999, MOVEMENT DISORD, V14, P725, DOI 10.1002/1531-8257(199909)14:5<725::AID-MDS1003>3.0.CO
[3] 2-L
[4] *MOV DIS SOC TASK, 2002, MOV DISORD S4, V17, pS1
[5] A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
Rascol, O
Brooks, DJ
Korczyn, AD
De Deyn, PP
Clarke, CE
Lang, AE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) : 1484 - 1491
[6] DEMOGRAPHIC DIFFERENCES IN REFERRAL RATES TO NEUROLOGISTS OF PATIENTS WITH SUSPECTED PARKINSONS-DISEASE - IMPLICATIONS FOR CASE-CONTROL STUDY DESIGN
RYBICKI, BA
JOHNSON, CC
GORELL, JM
[J]. NEUROEPIDEMIOLOGY, 1995, 14 (02) : 72 - 81
[7] Physicians' preferences for specialty involvement in the care of patients with neurological conditions
Swarztrauber, K
Vickrey, BG
Mittman, BS
[J]. MEDICAL CARE, 2002, 40 (12) : 1196 - 1209
[8] Weiner WJ, 1999, MOVEMENT DISORD, V14, P716, DOI 10.1002/1531-8257(199909)14:5<716::AID-MDS1002>3.0.CO
[9] 2-Q

← 1 →